All News #Library
Rare Diseases
Foundation for Sarcoidosis Research Responds to aTyr Pharma Trial
17 Sep 2025 //
GLOBENEWSWIRE
aTyr Flunks Phase 3 Lung Disease Trial, Deflating Stock
16 Sep 2025 //
REUTERS
European Commission Grants Orphan Drug Desig. for aTyr Pharma™s Efzofitimod
22 Jun 2023 //
GLOBENEWSWIRE
EC Grants Orphan Drug Designation for aTyr Pharma`s Efzofitimod for Sarcoidosis
18 Jan 2023 //
GLOBENEWSWIRE

Market Place
Sourcing Support